Company Search:
Advanced Search
Sponsored Links
IDL Biotech AB Company Snapshot
IDL Biotech AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other pharmaceutical manufacturers in Europe: Epigenomics AG of Germany (2015 sales of 2.08 million Euro [US$2.21 million] of which 75% was Product sales (own and third party)), Biohit Oyj of Finland (6.05 million Euro [US$6.43 million] ), and Asit Biotech SA which is based in Belgium (4,000.00 Euro [US$4,250.80 ] ).

Sales Analysis. IDL Biotech AB reported sales of SEK 28.52 million (US$3.19 million) for the year ending December of 2015. This represents an increase of 8.0% versus 2014, when the company's sales were SEK 26.40 million. This was the fourth straight year of sales growth at IDL Biotech AB.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
IDL Biotech AB
  Stock Performance Chart for IDL Biotech AB
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 3.25
(Figures in Swedish Kronor)
1 Week 1.6%   13 Weeks 1.9%  
4 Weeks 4.8%   52 Weeks 50.5%  
IDL Biotech AB Key Data:
  Ticker: IDL B Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 28,517,409
(Year Ending Jan 2016).
Employees: 12
  Currency: Swedish Kronor Market Cap: 88,849,114
  Fiscal Yr Ends: December Shares Outstanding: 27,338,189
  Share Type: B Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.